NCT04968106 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04968106
Title	Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Retroperitoneal Sarcomas (TORNADO) (TORNADO)
Acronym	TORNADO
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Institut Bergonié
Indications	retroperitoneal sarcoma
Therapies	Doxorubicin + Ifosfamide Doxorubicin + Ifosfamide + Retifanlimab
Age Groups:	adult \| senior
Covered Countries	FRA

Facility	City	Zip	Country	Details
Institut Bergonié	Bordeaux	33076	France	Details
Centre Léon Bérard	Lyon		France	Details
Institut Curie	Paris		France	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04968106Clinical Trial Detail